Mepitel Film for the Prevention of Radiation Dermatitis - A comprehensive review of its efficacy, side effects, physics measurements, patient- and clinician- reported outcomes

Objective This review aimed to summarize the benefits, side effects, physics measurements, and patient- and clinician-reported outcomes of Mepitel film (MF) in preventing radiation dermatitis (RD) for cancer patients. Methods The online database PubMed was searched from inception to April 15, 2024 with the search terms “Mepitel film” or “Mepitel”. Articles of any study design evaluating MF for the prevention of RD were included. Non-human studies were excluded. Results The database search identified 119 articles and 13 of them were included in this review. Across these studies, MF was found to be beneficial in reducing RD and improved patient- and clinician-reported outcomes in breast and head and neck cancers. Side effects of MF included itchiness, acne, allergic reaction, tightness, discomfort, and poor film adherence, but patient dropouts were uncommon. MF did not cause a bolus effect or increased skin dose in physics measurements. Conclusions MF is a safe and effective intervention for preventing acute RD. It should be recommended in breast cancer patients where the data is more robust. Further research is needed to evaluate MF’s efficacy on patients with different skin tones, its cost-effectiveness, and identifying patients who most benefit from MF relative to other effective interventions.